RNA Therapy Conferences
The RNA industry is rapidly evolving and entering a new era of growth, with more than 734 ongoing clinical trials, and 25 approved RNA therapeutics across the globe as drug developers race to advance the development of safe and efficacious RNA vaccines, therapeutics and genetic medicines. The field is rapidly expanding beyond rare diseases into larger patient indications including oncology, immunology, cardiovascular disease and more.
Our mission is to be the industry’s leading platform to accelerate the future of RNA platforms, technologies and innovations, by optimizing targeted and extrahepatic delivery, advancing next-generation RNA modalities and driving manufacturing scalability to expand RNA medicines into broader patient populations.